Related posts
Top Covid-19 Vaccine Stocks to Bet on the Immunization Race (Updated)Coronavirus : Stocks to Buy or Avoid (In Depth)This summary was created by AI, based on 1 opinions in the last 12 months.
Inovio Pharmaceuticals (INO-Q) has received mixed reviews from experts, with one expert expressing concern about its small size and volatility. This indicates that there are potential risks associated with investing in this stock. It is important for investors to carefully consider these factors before making any decisions. Overall, the company's performance and future prospects remain uncertain, and investors should proceed with caution when considering this stock.
Inovio Pharmaceuticals is a American stock, trading under the symbol INO-Q on the NASDAQ (INO). It is usually referred to as NASDAQ:INO or INO-Q
In the last year, there was no coverage of Inovio Pharmaceuticals published on Stockchase.
Inovio Pharmaceuticals was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Inovio Pharmaceuticals.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
0 stock analysts on Stockchase covered Inovio Pharmaceuticals In the last year. It is a trending stock that is worth watching.
On 2024-04-24, Inovio Pharmaceuticals (INO-Q) stock closed at a price of $10.1.